Skip to content
Welcome, thoughtbot's Giant Robots listeners!Start here
UK Startups and Innovation
7JUN

Apoha bets £26.7m on lab data

2 min read
10:09UTC

Apoha raised £26.7m on 3 June, led by Singular with an Innovate UK grant alongside the equity, wagering that lab-measured molecular data becomes a durable moat as AI models exhaust the public web.

TechnologyDeveloping
Key takeaway

Apoha is testing whether the value in AI shifts from the model to the proprietary physical dataset beneath it.

Apoha, a London deep-tech company, raised £26.7m ($36m) on Wednesday 3 June, led by European fund Singular, with Seedcamp, Draper Associates and Redalpine following and an Innovate UK grant alongside the equity. The company is building what it calls a layer of empirical data on how molecules actually behave, measured in a laboratory rather than scraped from the internet or generated by a model.⁠1

Large AI models have largely consumed the text available on the open web, and physical-world data cannot be synthesised the way more text can; it has to be measured in a lab. Apoha is betting that proprietary measured data on chemistry and materials becomes the scarce input, the moat that sits underneath the model rather than inside it. The AI Growth Zones building UK compute capacity supply the processing the bet assumes; the scarce asset Apoha is chasing is the data fed into it.

The wager carries a long fuse. Lab measurement at the scale Apoha describes takes years to accumulate, and the value of the dataset depends on whether AI systems reasoning about chemistry and materials actually need data a rival cannot simply download. The £26.7m buys the time to build it; whether the moat holds is the question the next few years answer.

Deep Analysis

In plain English

Most AI models learn from text found on the internet: books, articles, conversations. That works well for language tasks. But chemistry, materials science, and drug discovery require understanding how molecules actually behave, which cannot be derived from text descriptions alone. Apoha runs physical experiments to measure molecular behaviour directly: how chemicals react, how materials deform, how biological molecules fold. That measured data becomes the training material for AI models that need to reason about the physical world. The investment thesis is that this kind of data cannot be synthesised from internet text and takes years of lab work to generate, which creates a barrier that a well-funded competitor cannot simply replicate in six months.

Deep Analysis
Root Causes

Large language models have consumed approximately 90% of indexed internet text; further scale increases produce diminishing returns in language and reasoning tasks. The frontier for capability improvement has shifted to grounded physical-world data: satellite imagery, sensor feeds, scientific measurement data.

Apoha is one of a small cohort of companies (alongside Orbital Industries' atomic simulation engine and Isomorphic Labs' molecular structure work) betting that physical measurement data will be the next scarce input.

The Innovate UK grant alongside the equity is structurally important: Innovate UK's new portfolio management model (from April 2026) actively scouts companies in this category through its Growth Sector Teams, meaning Apoha likely received proactive outreach rather than winning a competitive grant application.

What could happen next?
  • Opportunity

    If the physical-data moat thesis holds, Apoha's position in materials and chemistry AI becomes more defensible as competitors' text-trained models hit capability ceilings.

  • Risk

    Open-source physics simulation datasets from academia (NIST, Cambridge Structural Database) could erode the scarcity premium of proprietary measured data if academic coverage expands into Apoha's target domains.

First Reported In

Update #7 · OQC's £260m sets European quantum record

UK Tech News· 7 Jun 2026
Read original →
Different Perspectives
Nscale and Open Cosmos
Nscale and Open Cosmos
Nscale chose the New York Stock Exchange for its listing on 18 September, putting Britain's largest AI infrastructure bet to American public investors rather than British ones. Open Cosmos took the opposite route four days earlier, raising nine figures from an all-domestic syndicate on five years of profit, evidence that staying is possible when the balance sheet allows it.
Dame Chi Onwurah and the Science, Innovation and Technology Committee
Dame Chi Onwurah and the Science, Innovation and Technology Committee
Committee chair Dame Chi Onwurah wrote to government on 7 September asking how Matt Clifford's conflict at ARIA arose and what safeguards protect its governance, and expects a detailed response. Her question has not yet been put to the Sovereign AI Unit, whose own chair sits at a venture capital firm while overseeing state AI equity.
The Entrepreneurs Network
The Entrepreneurs Network
The Entrepreneurs Network's founder survey found 65% say Britain is easy to start a business in but only 14% say it is easy to scale one, with 82% negative on tax and 74% finding investment hard to access. On this reading the constraint is regulation and tax, not the capital-vehicle design the state keeps adjusting.
New Economics Foundation
New Economics Foundation
The New Economics Foundation argues fiscal accounting rules, not political will, cap what Britain's state capital vehicles can do. Matching the KfW and Bpifrance benchmark of 1% of GDP would need the National Wealth Fund to deploy roughly GBP21bn a year by 2028-29, about four times its current capacity.
Competition and Markets Authority
Competition and Markets Authority
The CMA's 8 September report on public procurement asked whether Britain's roughly GBP400bn state-spending system is built to grow high-potential firms rather than simply widen SME participation. Its Recommendation 5 calls for a dedicated frontier-technology procurement framework, an official acknowledgement that today's design may serve the wrong target.
Highland Europe
Highland Europe
Highland Europe, the growth-equity firm behind a €1bn-plus fund, took €65m from the British Business Bank into its Technology Growth Fund VI on 30 July via British Patient Capital. For a Geneva-based growth investor, the Bank's cheque is routine cornerstone capital, unrelated to which Whitehall department currently claims to sponsor UKRI.

AI-assisted, human-edited under the editorial responsibility of Bannermedia Ltd. Reviewed by Ed Woodcock on 7 June 2026. Editorial standards.